Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gadd45a acts as a modifier locus for lymphoblastic lymphoma.

M C Hollander1, A D Patterson, J M Salvador

  • 1Gene Response Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. ch96b@nih.gov

Leukemia
|March 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children's Oncology Group Report.

Leukemia·2024
Same author

Interaction of sodium acetate supplementation and dietary fiber level on feeding behavior, digestibility, milk synthesis, and plasma metabolites.

Journal of dairy science·2022
Same author

Effect of 2-hydroxy-4-(methylthio)butanoate (HMTBa) on milk fat, rumen environment and biohydrogenation, and rumen protozoa in lactating cows fed diets with increased risk for milk fat depression.

Journal of dairy science·2022
Same author

Comparison of the effects of short-term feeding of sodium acetate and sodium bicarbonate on milk fat production.

Journal of dairy science·2021
Same author

The association of lipophilic phospholipids with native bovine casein micelles in skim milk: Effect of lactation stage and casein micelle size.

Journal of dairy science·2018
Same author

Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia.

Leukemia·2017
Same journal

Evolutionary considerations for risk stratification in TP53-variant myeloproliferative neoplasms.

Leukemia·2026
Same journal

Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies.

Leukemia·2026
Same journal

Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.

Leukemia·2026
Same journal

Redefining light-chain smoldering multiple myeloma: prevalence and progression risk.

Leukemia·2026
Same journal

Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II.

Leukemia·2026
Same journal

Retroperitoneal bulk predicts chylothorax in follicular lymphoma-control requires systemic response.

Leukemia·2026
See all related articles

Deletion of the GADD45A gene accelerates T-cell lymphoma development in mice lacking the p53 gene. GADD45A acts as a modifier locus, influencing tumor type and latency in these models.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • GADD45A and p53 proteins are involved in a regulatory feedback loop.
  • Mice lacking either GADD45A or p53 exhibit genomic instability.
  • p53 knockout mice rapidly develop diverse neoplasms, unlike GADD45A knockout mice.

Purpose of the Study:

  • To investigate the combined effect of GADD45A and p53 gene deletion on tumor development.
  • To determine if GADD45A acts as a modifier locus in T-cell lymphomagenesis.

Main Methods:

  • Generation and analysis of GADD45A-/-p53-/- double knockout mice.
  • Assessment of tumor latency and type in knockout mouse models.
  • Evaluation of Gadd45a deletion impact on lymphoma-prone AKR mice.

Related Experiment Videos

Main Results:

  • GADD45A-/-p53-/- mice developed tumors with similar latency to p53-/- mice.
  • Nearly all GADD45A-/-p53-/- mice developed lymphoblastic lymphoma (LBL), unlike the varied tumors in p53-/- mice.
  • Gadd45a deletion decreased latency for LBL in susceptible mice, indicating a modifier role.

Conclusions:

  • GADD45A acts as a modifier locus for T-cell lymphoblastic lymphoma.
  • Deletion of GADD45A enhances T-cell LBL development in susceptible genetic backgrounds.
  • While human samples lacked GADD45A deletion/mutation, expression changes are possible.